Monte Rosa Therapeutics, Inc. - Common Stock, par value $0.0001 per share (GLUE)
CUSIP: 61225M102
Q2 2024 13F Holders as of 30 Jun 2024
- Type / Class
- Equity / Common Stock, par value $0.0001 per share
- Shares outstanding
- 80,381,753
- Total 13F shares
- 45,836,316
- Share change
- +5,937,410
- Total reported value
- $171,427,053
- Put/Call ratio
- 24%
- Price per share
- $3.74
- Number of holders
- 73
- Value change
- +$21,976,071
- Number of buys
- 44
- Number of sells
- 18
Quarterly Holders Quick Answers
What is CUSIP 61225M102?
CUSIP 61225M102 identifies GLUE - Monte Rosa Therapeutics, Inc. - Common Stock, par value $0.0001 per share in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Related Filing Research
- Latest 13F filings for newly reported positions.
- Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
- Latest 10-Q/10-K reports for financial context tied to this issuer.
- Recent insider transactions for executive and insider activity.
- SEC investors directory and top value investors for manager drilldown.
- Back to full security ownership history.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 61225M102:
Institutional Holders of Monte Rosa Therapeutics, Inc. - Common Stock, par value $0.0001 per share (GLUE) as of Q2 2024
As of 30 Jun 2024,
Monte Rosa Therapeutics, Inc. - Common Stock, par value $0.0001 per share (GLUE) was held by
73 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
45,836,316 shares.
The largest 10 holders included
NEA Management Company, LLC, PRICE T ROWE ASSOCIATES INC /MD/, FMR LLC, BAKER BROS. ADVISORS LP, Avoro Capital Advisors LLC, SUVRETTA CAPITAL MANAGEMENT, LLC, VANGUARD GROUP INC, BlackRock Inc., Aisling Capital Management LP, and Alphabet Inc..
This page lists
73
institutional shareholders reporting positions in this security
for the Q2 2024 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2024 vs Q1 2024 Across Filers
Q1 2024 holders
67
Q2 2024 holders
73
Holder diff
6
| Investor | Q1 2024 Shares | Q2 2024 Shares | Share Diff | Share Chg % | Q1 2024 Value $ | Q2 2024 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.